Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Should we feel free to use loco-regional anesthesia in multiple sclerosis?
Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis.
Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
Leukoencephalopathy due to Oral Methotrexate.
A modified superantigen rescues Ly6G(-)CD11b(+)blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE.
Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Simulating neurodegeneration through longitudinal population analysis of structural and diffusion weighted MRI data.
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Phosphodiesterases in neurodegenerative disorders.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.
Low body weight linked to PML risk with natalizumab in MS
Multiple sclerosis in Syria.
Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.

Pages